ABSTRACT | Small animal dosimetry serves as an important link in establishing a relationship between absorbed dose and biological effect during preclinical targeted radionuclide therapy. Dosimetric approaches reported to date are based on models aiming at representing the animals used during preclinical experiments. However, anatomical variations between models may generate differences in the dosimetric results. Our goal was to assess the impact of the mouse model on the absorbed dose per cumulated activity (S-value, in gray per becquerel-seconds).
I. INTRODUCTION
Targeted radionuclide therapy (TRT) is a cancer treatment modality in which a biologic vector conveys a radioactive isotope to the neighborhood of cancer targets, thus concentrating radiations with the ultimate goal of selectively irradiating tumor cells [1] . The vector can be the nuclide itself, as is the case in the treatment of differentiated thyroid cancer with 131-iodine. The vector can be a monoclonal antibody targeting antigens specific to cancer cells (thus defining radioimmunotherapy), a metabolite, or a peptide. The radionuclide must preserve the targeting specificity by emitting short-range radiations. Beta emitters are usually used for this purpose, even though the potential of alpha or Auger emitters is being considered [2] . Targeted radionuclide therapy has demonstrated its potential in the therapy of radiosensitive non-Hodgkins B-lymphoma [3] , [4] , melanoma [5] , or neuroendocrine tumors [6] .
Small animal dosimetry serves as an important link in establishing a relationship between absorbed dose and biological effect (toxicity or efficacy) during preclinical targeted radionuclide therapy.
The absorbed dose can be derived according to the Medical Internal Radiation Dose (MIRD) formalism [7] D ðk hÞ ¼Ã h Á S ðk hÞ where: D ðk hÞ mean absorbed dose in gray (Gy) to the target k from radiation emitted by the source h; A h cumulated activity in becquerel-seconds (Bq.s) in the source region h; S ðk hÞ mean absorbed dose in gray per becquerelsecond to the target k per unit cumulated activity in the source h (or S-value). As can be seen from the above equation, absorbed dose calculation requires both the cumulated activity and the S-value to be determined.
The cumulated activity is usually determined from measurements of activity in organs/tissues at different time points after injection of a radiopharmaceutical. Animals are sacrificed and dissected and the organ/tissue is weighed and measured for activity, thus yielding the mean/standard deviation of activity concentration at various time points. The selected animals are usually of the same age and strain for better homogeneity of the results. The cumulated activity is calculated as the time integral of the activity as a function of time after the injection.
Computational phantoms based on a realistic anatomy are needed to quantify organ average absorbed doses [8] . Several authors have proposed murine S-values, using stylized phantoms (mathematical models) [9] - [12] and, more recently, anatomical voxel-based models [13] - [15] . This is an important step since, contrary to the situation in clinical dosimetry, the range of the particles involved in TRT is of the same order of magnitude as the dimensions of the small animal organs and tissues of interest. S-values should therefore not be calculated under the assumption that radiation is nonpenetrating (the absorbed fraction equals one). An explicit model of radiation transport has to be considered for most organ/ tissues of interest in murine dosimetry. In addition, even in situations where the activity distribution is homogeneous within source organs, the absorbed dose distribution is likely to be heterogeneous because of the finite range of the beta particle, thus warranting a voxel-based absorbed dose calculation.
Since cumulated activities are obtained by averaging measurements obtained from several animals, it is usual to consider S-values obtained from a reference mouse or rat model rather than on the specific animal that has been used for the experiment. Still, several arguments questioning the relevance of the murine model have been raised, including the following.
/ Different strains of mice yield animals of different sizes and shapes. Organ geometries might be affected, thus producing different S-values. It is therefore important to use S-values that have been developed for the animal strain considered in the study or to be able to adjust S-values computed for a given animal model to a more relevant one. / Tumor models cannot be explicitly integrated within a Breference[ mouse model. Tumor dosimetry must therefore be considered separately. More recently, quantitative imaging has paved the way for longitudinal studies [16] , allowing the pharmacokinetics to be determined for each individual animal. The accuracy of such an approach remains to be ascertained. Operational issues such as the ability to sequentially anesthetize the same animal safely, or to fuse images obtained at different time points with accuracy on par with the spatial resolution of the imaging devices, have to be addressed [17] . The radiation burden resulting from the sequential use of microCT is generally not lethal, but the absorbed dose levels may be sufficient to induce deterministic effects that could confound the biological outcome of the experiment [18] . Still, it must be considered that animalspecific pharmacokinetics are or will be available within the near future from microimaging devices (micro-PET/CT or micro-SPECT/CT). In that context, the relevance of model-based dosimetry may have to be reconsidered: If cumulated activities can be obtained for a given animal, then, on principle, the absorbed dose should be determined for the animal itself rather than for a model unless it can be proven that using a model does not impact the dosimetric results markedly.
Absorbed dose calculations can be performed using different approaches. Monte Carlo codes can be used to follow radiation transport and score energy deposition. When compared to less refined approaches such as dose point kernel convolutions, Monte Carlo approaches have the advantage of being able to correctly account for the heterogeneous materials (soft tissue, bone, lung, air) present within animal bodies. The price to pay (independently of the inherent complexity of most Monte Carlo packages available to the scientific community) is that Monte Carlobased calculations usually require intensive computing capabilities, thus restricting the adoption of the approach to a limited number of laboratories.
The main goal of this work therefore was to assess the impact of anatomical variation on murine S-values. Two murine dosimetric models developed in our laboratory were considered. Our models were scaled to other models presented in the literature, so that S-values could be compared for different mouse models of the same total body-weight.
II. MATERIALS AND METHODS

A. Model Definition
This work exploited two three-dimensional (3-D) segmented datasets created according to the following protocol: A mouse was embedded into a frozen block, which was then mounted on the moving table of a cryomicrotome and sectioned into 100 m slices. High-resolution digital photographs were taken of each section. The first dataset was developed by Bitar et al. in our laboratory [13] . It is based on a 30-g Naval Medical Research Institute (NMRI) female athymic nude mouse. Manual image segmentation led to the identification of 30 regions (organs and suborgans). Original data were stored in tiff format, with each pixel index number representing an organ or suborgan (bladder wall, bladder content, left and right limb bones, brain, colon, heart, left and right kidney medulla, left and right kidneys cortex, liver, left and right lungs, bone marrow in femurs and legs, left and right ovaries, pancreas, skull, small intestine, spleen, spinal cord, stomach wall, stomach contents, left and right suprarenal glands, thyroid, uterus, vertebrae, fat, and carcass). Additionally, tumors have to be inserted into this geometry to represent particular preclinical conditions [19] .
The second dataset originates from the Digimouse project [20] and is based on a 28-g normal nude male mouse. The 3-D atlas, initially designed for brain imaging, is composed of nine brain regions (whole brain, external cerebrum, cerebellum, olfactory bulbs, striatum, medulla, massetter muscles, eyes, and lachrymal glands, ) and 12 other organs (heart, lungs, liver, stomach, spleen, pancreas, adrenal glands, kidneys, testes, bladder, skeleton, and carcass). In the study reported in this paper, our results were compared with data published previously by Stabin et al. [14] and Larsson et al. [15] . The model considered by Stabin et al. is a transgenic mouse (body mass 27 g), imaged using a dedicated small-animal CT scanner (256 Â 256 Â 256 matrix with voxel size 0.2 mm). Identified organs were segmented from the CT slices (kidneys, liver, lungs, spleen, heart, stomach, intestines, skeleton, testes, and bladder). The second study used the Moby phantom [21] , based on a segmented C57BL/6 mouse (body mass 33 g). Threedimensional magnetic resonance microscopy was used to create nonuniform rational B-spline (NURBS) representing the organ shapes. A matrix of 128 Â 128 Â 432 elements with a voxel size of 0.25 mm was generated. Organ masses for that anatomical atlas were calculated by Taschereau et al. [22] in order to derive absorbed doses for use within the context of 18-fluorine compounds used in PET imaging experiments.
Our two mouse datasets were down-sampled to match the scale of the other models [14] , [15] . The female phantom was stored in a matrix of 220 Â 450 Â 111 voxels of 0:222 Â 0:222 Â 0:2 mm 3 . The nude male atlas was stored using 190 Â 496 Â 104 matrix elements, with a voxel size of 0.2 mm. Tissue densities and chemical composition were taken from ICRU Report 44 [23] except for the bladder wall, bladder content, colon, small intestine, stomach wall, and stomach contents, which were obtained from Woodard et al. [24] . Table 1 summarizes the characteristics of the models considered in this study and Table 2 provides the density references used for each model.
B. MCNPX Monte Carlo Simulations
The previous work published by Bitar et al. was performed using the MCNP4c2 Monte Carlo code [25] .
However, more recent versions of MCNP and MCNPX 2.5 [27] have implemented new features, such as scoring and source sampling using a repeated structures representation that increases computing performance for voxel-based geometries. In order to check the consistency of the results produced by the two versions of the code, we first computed S-values with the two codes while keeping the geometrical model and isotope data constant.
We calculated S-values from absorbed energy distributions obtained with the Monte Carlo N-particle MCNPX transport code. All simulations were run on a MacBookPro (Apple) 2.16-GHz Intel Core 2 Duo with 3 GB RAM. A variance reduction technique was used and all particles transported from a region of higher importance (organ regions) to a region of lower importance (background air voxels) underwent a geometry splitting with Russian roulette [26] . Preliminary tests insured that implementing variance reduction did not modify the end results. Each mouse organ was simulated as a radiation source, assuming a uniform activity distribution in each. Radionuclide energy spectra were taken from ICRP Publication 38 [28] . The number of histories was chosen so as to keep the statistical uncertainties below 3%.
C. Variations Between Different Mouse Models
The models considered in this study are based on different mouse strains but have similar masses: 30 g for the female athymic nude mouse, 28 g for the normal nude male mouse, 27 g for the model proposed by Stabin et al., and 33 g for MOBY (Table 1) . In order to reduce the influence of the global volume of each model studied, we decided to scale the various models to the same total mass.
For that purpose, an interactive editing tool was developed specifically: Bmodel generator.[ The software's main goals are the fast and automatic generation of an input file for the Monte Carlo code (MCNP or MCNPX) used to simulate radiation transport and score energy deposition. The tool reads the 3-D atlas slice by slice and crops around the mouse volume to remove background air voxels. A label associates each voxel to a defined tissue type, with a density value and a material description. The whole body mass is entered into the model generator. 131 I were generated from the original Digimouse model (28 g ) and compared to the results obtained from the same male model scaled at 30 g (Table 6 ). All comparisons were made on a subset of organs identified in all models: liver, skeleton, stomach, kidneys, lungs, heart, spleen, pancreas, bladder, testes (for males [14] , [15] , [20] ), ovaries (for female [13] ), and the remainder of the body.
III. RESULTS
A. Comparison of S-Values From MCNP4c2 Versus MCNPX
Our approach using the model generator was compared to previously published result, with the same voxel-based model [19] but different MCNP code versions. As an example, Table 7 shows the S-values of three source/target organ combinations (kidneys, lungs, and liver) for 131-iodine. The differences in the S-values (Gy/Bq.s) were less than AE2%. Additionally, the gain in terms of computing speed was greater than 50% as compared to original MCNP4c2 runtimes. Since both simulations were run on the same hardware/operating system, this computing efficiency increase can be attributed to the implementation of variance reduction techniques and algorithmic improvements introduced in recent MCNP versions [29] .
B. Impact of Mouse Weight
Figs. 2 and 3 present the absorbed fractions (AFs) obtained by Monte Carlo modeling for 100 keV photon sources located in the liver for the dosimetric mouse models considered in the study.
Our two models (female model proposed by Bitar et al. and male model from Digimouse) were scaled to 27 g using our model generator in order to match the total weight of the mouse model proposed by Stabin et al. and then scaled to 33 g in order to match the total weight of the mouse model proposed by Larsson et al. As can be seen from Tables 2 and 3 , the scaling process did not entirely compensate for the differences in organ weights observed with different mouse strains or gender. This translates into varying AFs, even for models of an equivalent total mass. The self-absorbed fractions (liver to liver) were significantly different (1.47E À2 , 1.24E À2 , and 9.32E À3 ) for the 27-g models (Fig. 1) and closer (1.58E À2 , 1.33E À2 , and 1.7E À2 ) for the 33-g models (Fig. 2) and generally followed liver mass variations. Cross-absorbed fractions also varied markedly between models, except for some combinations where target organ masses were close (liver to kidneys for Bitar's and Stabin's models in Fig. 2 ; liver to heart for Digimouse and Bitar's model in Figs. 2 and 3) .
Figs. 4 and 5 represent the absorbed fractions obtained by Monte Carlo simulation for 1 MeV electron sources located in the lungs for the dosimetric mouse models considered in the study. Values lower than 1E
À4 were set to zero on the graph. Self-absorbed fractions were usually similar between models, a fact that can be explained by the smaller range of electrons in tissues. Cross-absorbed fractions varied between models (for example, in the case of lung to heart or lung to skeleton), a fact that can be explained by the different methods used to segment datasets. Additionally, it must be stressed that the ribs and sternum Table 5 shows the ratios of the S-values generated by two models of the same strain (nude mouse) with the same whole body mass, postscaling. The Digimouse voxelbased model was scaled using the model generator from 28 to 30 g in order to match the female-model total body mass. The differences in organ masses before scaling were important (0.134 versus 0.123 g for lungs, 2.64 versus 1.83 g for liver, and 0.652 versus 0.754 g for kidneys), and the transformation from a 28-to a 30-g model did not compensate for the original differences. The resulting differences in terms of S-values were very pronounced (between 7.47 and 43.13%). Indeed, organ size and shapes do differ between the two models, as can be seen from the visualization of the phantoms in Fig. 1(a) and (b) . Table 6 compares 131-I S-values from the original male mouse model (28 g) against S-values for the same model scaled to 30 g. The total-body mass scaled model demonstrates different organ masses, volumes, and shapes. 
IV. DISCUSSION
The model-based mouse dosimetry literature has been recently extended by the presentation of three voxel-based models representing different mouse strains (Stabin et al. [14] , Bitar et al. [13] , and Larsson et al. [15] ). In this paper, we also introduce a male nude mouse dosimetric model based on the Digimouse atlas [20] .
Since it has been shown previously that varying mouse sizes may lead to important S-values variations [12] , we developed a mouse model generator that scales a given model to a predetermined total mass and generates an MCNPX input file in order to reduce computation times by eliminating segmentation stage. However, it appears that the linear total-body mass scaling does not correctly model the variations in organ size, shape, and location. Consequently absorbed fractions or S-values obtained from the various scaled models can be very different.
In addition to differences in strain or gender, the production of the voxel representation of the various models was not equivalent: Stabin's model was obtained from microCT slices of a living animal, segmented with standard image-processing tools available on a commercial workstation. No reference to the original animal strain was given in the paper. The transgenic nature of the mouse considered in Stabin's study may explain the unusually low weight of the liver (0.78 g). MOBY's original dataset was obtained from images of a living animal (using magnetic resonance imaging), whereas our two dosimetric models were obtained by manual segmentation of cryosections of a dead animal. Imaging and segmentation methodologies, combined with differences in original strains and gender, probably all contribute to the observed variations in organ shape and mass, even for total-body mass scaled models. Interestingly, even very similar models (Digimouse and Bitar's model) with similar original total-body weights (28 and 30 g) still demonstrate quite different organ masses.
This raises several questions regarding the relevance of Breference models[ for mouse dosimetry. If the purpose of a given study is to compare the dosimetry of different isotopes (for example, high-versus low-energy beta emitters), then the use of a similar geometryVhence a reference mouse modelVto perform the comparison is probably wise.
In all other situations, the dosimetric model should match as closely as possible the geometric characteristics of the mouse strain of interest for the study. A linear transformation such as that conducted in our study may not be sufficient to Badapt[ a single model to different mouse strains.
Some further issues should be investigated. First, animals selected for a given preclinical experiment are usually chosen from amongst mice of the same age and strain. The study of the variation in organ masses and shape in a similar animal batch is under way in order to determine if a Brepresentative[ mouse from the experimental batch may be used as a reference for dosimetric studies. This might lead to a range of Brepresentative[ mouse models, a possibility that can be considered due to current computation capabilities and the finite number of animal strains used in preclinical experiments. Another area to explore is the possibility of adapting our model generator to give a correct interpolation between mice from the same strain but differing in age, or even between mice from different strains. This would require implementing more advanced registration methods than linear interpolation. As an alternative, adapting NURBS-based phantoms, like MOBY, for example, is certainly worth consideration.
Mouse-specific dosimetry is yet another possibility to explore. In that situation, mouse-specific biokinetics obtained from sequential quantitative imaging would be used to derive absorbed dose estimates for every animal under investigation. As was seen in the Introduction, real mousespecific dosimetry still represents a scientific challenge, for many reasons. However, as far as the absorbed dose calculation alone is concerned, the use of state-of-the-art Monte Carlo codes such as those used in this paper that couple sound and reliable radiation transport physics with dedicated algorithms to increase computation speed in a voxel-based geometry is becoming a viable option. Computation times required to perform whole-body absorbed dose calculations are now on the order of hours using commercially available computers, a value that can easily be reduced by the use of computer clusters that are remarkably efficient for Bembarrassingly parallel problems[ such as those involved in absorbed dose calculations.
V. CONCLUSION
In a previous publication, we introduced a voxel-based dosimetric model of a female nude mouse [13] . In this paper, we present a nude male mouse dosimetric model. A software tool was developed to facilitate the creation of additional murine dosimetric models based on our two original datasets by scaling the total-body mass. However, comparison between our models and those presented by other authors demonstrates that even total-body mass scaled models exhibit different organ masses, volumes, and shapes. This obviously leads to variations in calculated S-values. Additional work is in progress to determine if, within the same strain and for animals of the same age, geometric variations between samples for the same experimental batch are small enough to warrant the generation of a representative mouse dosimetric model, for a given type of preclinical experiment. A possible alternative would be to use image-based mouse geometry and pharmacokinetics to derive mouse-specific absorbed dose calculations. This certainly is feasible from a computing perspective. Still, mouse-specific dosimetry needs to be validated as a viable option for preclinical experiments. h
